EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Monthly Return of Equity Issuer on Movements in Securities
DISCLOSEABLE TRANSACTION PURCHASE OF STRUCTURED DEPOSIT
Monthly Return of Equity Issuer on Movements in Securities
NOTICE OF BOARD MEETING
VOLUNTARY ANNOUNCEMENT INITIATION OF PHASE III CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR ABSORBED TETANUS VACCINE
VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF DRUG REGISTRATION APPLICATION FOR 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (CRM197, TT VECTOR)
INSIDE INFORMATION UPDATES ON 2023 PRELIMINARY ANNUAL RESULTS
ELECTIONS RELATING TO BOARD OF DIRECTORS, BOARD COMMITTEES AND BOARD OF SUPERVISORS
List of Directors and their Roles and Functions
1
2
3
4
5
6
44